We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis.
- Authors
Malling, H-J; Montagut, A; Melac, M; Patriarca, G; Panzner, P; Seberova, E; Didier, A
- Abstract
The optimal dose of grass pollen tablets for sublingual immunotherapy (SLIT) in allergic rhinoconjunctivitis patients was previously established in a multinational, randomized, double-blind, placebo-controlled study in 628 adults. Patients were randomized to receive once-daily 5-grass pollen sublingual tablets of 100 IR (index of reactivity), 300 IR or 500 IR, or placebo starting 4 months before the pollen season.
- Publication
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2009, Vol 39, Issue 3, p387
- ISSN
1365-2222
- Publication type
Journal Article
- DOI
10.1111/j.1365-2222.2008.03152.x